SHR0302 not checked

Hengrui

FollowEvery change as it happens, and a Monday email
Stage
in China
Next date
Phase 3 trial completes
Trials
3 active
14 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Psoriatic Arthritis, Vitiligo, Non-segmental Vitiligo
Main trialPhase 3
“This study is a phase 3 study,to evaluate the efficacy and safety of different doses of JAK1 inhibitor SHR0302 in subjects with active psoriatic arthritis.”In the company’s words, NCT04957550 on ClinicalTrials.gov

Other drugs for Psoriatic Arthritis

All 29 drugs for Psoriatic Arthritis

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials14

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting 13 Dec 2026 To Evaluate the Efficacy and Safety of SHR0302 Tablet in Subjects of Active Psoriatic Arthritis
Phase 2Active, not recruiting 3 Mar 2026 A Trial of SHR0302Base in Patients With Vitiligo
Phase 2Recruiting Mar 2027 A Trial of SHR0302 Tablets and SHR0302 Base Gel in Patients With Non-segmental Vitiligo
Phase 3Completed 30 Jan 2023 A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Rheumatoid Arthritis
Phase 3Unknown 30 Aug 2024 A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Non-Radiographic Axial Spondyloarthritis
Phase 2/3Completed 15 Nov 2022 A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Ankylosing Spondylitis
Phase 2Completed 16 Apr 2019 Study of SHR0302 Tablets (SHR0302) as Monotherapy in Active Rheumatoid Arthritis (RA) Patients
Phase 1Completed 27 Dec 2020 Pharmacokinetics and Safety of SHR0302 in Patients With Hepatic Impairment
Phase 1Completed 13 Apr 2021 Study on the Bioavailability of SHR0302 in Healthy Subjects
Phase 1Completed 19 Sep 2021 A Study of Human Substance Balance and Biotransformation of [14C]SHR0302
Phase 1Completed 18 Aug 2022 A Pharmacokinetic Study to Evaluate the Drug Interaction Between SHR0302 and CYP Substrates in Healthy Volunteers
Phase 1Completed 3 Jul 2023 To Assess SHR0302 Oral Solutions and Tablets in Healthy Subjects Clinical Studies of Relative Bioavailability
Phase 1Completed 21 Feb 2024 A SHR0302 BA Study on Healthy Subjects
Phase 1Completed 31 Jul 2024 A Randomized, Double-blind, Placebo-controlled Phase I Clinical Trial to Evaluate the Safety and Pharmacokinetic Profile of Single and Multiple Dose Escalation Topical Dermal Administration of SHR0302 Alkali Gel in Healthy Subjects
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow SHR0302

Following is part of Solo: you see every change to SHR0302 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in